{Reference Type}: Journal Article
{Title}: MYBIOTA: A birth cohort on maternal and infant microbiota and its impact on infant health in Malaysia.
{Author}: Eow SY;Gan WY;Jiang T;Loh SP;Lee LJ;Chin YS;Than LTL;How KN;Thong PL;Liu Y;Zhao J;Chen L;
{Journal}: Front Nutr
{Volume}: 9
{Issue}: 0
{Year}: 2022
{Factor}: 6.59
{DOI}: 10.3389/fnut.2022.994607
{Abstract}: <B>UNASSIGNED: </B>The microbiota plays a key role in early immunity maturation that affects infant health and is associated with the development of non-communicable diseases and allergies in later life.<BR><B>UNASSIGNED: </B>The MYBIOTA is a prospective mother-infant cohort study in Malaysia aiming to determine the association between gut microbiota with infant health (temperament, gastrointestinal disorders, eczema, asthma, and developmental delays) in Selangor, Malaysia.<BR><B>UNASSIGNED: </B>Pregnant mothers will be enrolled in their first trimester of pregnancy, and follow-ups will be done for infants during their first year of life. Maternal-infant biological samples (blood, feces, saliva, urine, and breast milk), anthropometric, dietary, and clinical information will be collected at different time points from early pregnancy to 12 months postpartum.<BR><B>UNASSIGNED: </B>This study could provide a better understanding of the colonization and development of the gut microbiome during early life and its impact on infant health.<BR><B>UNASSIGNED: </B>https://clinicaltrials.gov/, identifier NCT04919265.